US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

The Oncology Institute

6.37

-0.1500-2.30%

Post-market: 6.370.00000.00%19:30 EDT

Volume:1.17M

Turnover:7.49M

Market Cap:649.21M

PE:-20.94

High:6.57

Open:6.42

Low:6.31

Close:6.52

52wk High:7.05

52wk Low:2.32

Shares:101.92M

Float Shares:88.60M

Volume Ratio:1.05

T/O Rate:1.32%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.3042

EPS(LYR):-0.5445

ROE:--

ROA:-9.65%

PB:-26.06

PE(LYR):-11.70

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Starling Oncology Forecasts Fy2026 Revenue of $650-670 Million

Starling Oncology - Brad Hively no Longer Serves as Vice Chairman or Committee Member Effective Immediately - SEC Filing

THOMSON REUTERS

Starling Oncology - Brad Hively Will not Stand for Re-Election to Starling Oncology Board at 2027 Annual Meeting - SEC Filing

THOMSON REUTERS

Starling Oncology Director Brad Hively to Step Down as Vice Chairman, not Seek Re-Election in 2027

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/STLN"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"STLN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","market":"US","secType":"STK","nameCN":"The Oncology Institute","latestPrice":6.37,"timestamp":1789502400000,"preClose":6.52,"halted":0,"volume":1173934,"hourTrading":{"tag":"盘后","latestPrice":6.37,"preClose":6.37,"latestTime":"19:30 EDT","volume":12216,"amount":77815.76729999999,"timestamp":1789515005067,"change":0,"changeRate":0,"amplitude":0.00157},"delay":0,"changeRate":-0.023006134969325073,"floatShares":88601299,"shares":101916100,"eps":-0.304237,"marketStatus":"Post-Mkt","change":-0.15,"latestTime":"09-15 19:46:25 EDT","open":6.42,"high":6.5714,"low":6.31,"amount":7490334.018294,"amplitude":0.040092,"askPrice":6.37,"askSize":15,"bidPrice":6.34,"bidSize":4,"shortable":3,"etf":0,"ttmEps":-0.304237,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1789516800000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":6.52,"preHourTrading":{"tag":"盘前","latestPrice":6.42,"preClose":6.52,"latestTime":"09:28 EDT","volume":5,"amount":32.2,"timestamp":1789478885026,"change":-0.1,"changeRate":-0.015337,"amplitude":0.015337},"postHourTrading":{"tag":"盘后","latestPrice":6.37,"preClose":6.37,"latestTime":"19:30 EDT","volume":12216,"amount":77815.76729999999,"timestamp":1789515005067,"change":0,"changeRate":0,"amplitude":0.00157},"volumeRatio":1.048536,"impliedVol":1.2998,"impliedVolPercentile":0.9},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"STLN\",,,,,undefined,":{"symbol":"STLN","floatShares":88601299,"roa":"-9.65%","roe":"--","lyrEps":-0.544488,"volumeRatio":1.048536,"shares":101916100,"dividePrice":0,"high":6.5714,"amplitude":0.040092,"preClose":6.52,"low":6.31,"week52Low":2.32,"pbRate":"-26.06","psRate":"1.11","week52High":7.05,"institutionHeld":0,"latestPrice":6.37,"committee":-0.578947,"eps":-0.304237,"divideRate":0,"volume":1173934,"delay":0,"ttmEps":-0.304237,"open":6.42,"prevYearClose":3.56,"prevWeekClose":6.17,"prevMonthClose":5.91,"prevQuarterClose":5.43,"fiveDayClose":6.32,"twentyDayClose":6.31,"sixtyDayClose":5.26},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/STLN\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-06","symbol":"STLN","fiscalQuarterEnding":"2026/06","expectedEps":-0.07,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1785988800000,"reportTimeType":"post","actualEps":-0.08},{"date":"2026-05-06","symbol":"STLN","type":"earning","reportTimeType":"post","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1778097600000,"name":null,"time":"Post-Mkt","dateTimestamp":1778040000000,"actualEps":null},{"market":"US","date":"2026-03-12","symbol":"STLN","fiscalQuarterEnding":"2025/12","expectedEps":-0.08,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1773288000000,"reportTimeType":"post","actualEps":-0.06},{"market":"US","date":"2025-11-13","symbol":"STLN","fiscalQuarterEnding":"2025/09","expectedEps":-0.12,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1763010000000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-08-13","symbol":"STLN","fiscalQuarterEnding":"2025/06","expectedEps":-0.14,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755057600000,"reportTimeType":"post","actualEps":-0.15}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"STLN\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"STLN\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2,"buy":0.8,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.8,"analysts":5,"updateTime":1783396800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/STLN\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"STLN","date":"2026-09-14","current":-20.937624,"percent":0.571429,"low":-18.702266,"twenty":-17.98338,"median":-17.410518,"eighty":-16.669167,"high":-11.557791,"avg":-16.842027,"sd":1.937151,"marketCap":628822429},"quantilePoints":[{"date":"2026-08-07","current":-13.746861,"twenty":-12.626432,"median":-11.833524,"eighty":-11.695657,"marketCap":498914835},{"date":"2026-08-14","current":-17.579006,"twenty":-17.646402,"median":-17.298192,"eighty":-11.842715,"marketCap":637994879},{"date":"2026-08-21","current":-18.365288,"twenty":-18.045159,"median":-17.64921,"eighty":-12.999908,"marketCap":666531392},{"date":"2026-08-28","current":-17.803658,"twenty":-18.129404,"median":-17.719414,"eighty":-15.827113,"marketCap":646148169},{"date":"2026-09-04","current":-16.764643,"twenty":-18.045159,"median":-17.487741,"eighty":-16.646701,"marketCap":608439206},{"date":"2026-09-11","current":-17.410518,"twenty":-17.988996,"median":-17.494762,"eighty":-16.66355,"marketCap":631879913},{"date":"2026-09-14","current":-17.326273,"twenty":-17.98338,"median":-17.410518,"eighty":-16.669167,"marketCap":628822429}],"updateTime":1789515985098},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"STLN\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666582310","title":"Starling Oncology Forecasts Fy2026 Revenue of $650-670 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2666582310","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666582310?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:38","pubTimestamp":1788950292,"startTime":"0","endTime":"0","summary":"Starling Oncology forecasts FY2026 revenue of $650-670 millionStarling Oncology forecast FY26 revenue of USD 650-670 million, based on guidance reiterated in its Aug. 6, 2026 2Q26 release.Adjusted EBI","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nNDL1fb2rf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818219","title":"Starling Oncology - Brad Hively no Longer Serves as Vice Chairman or Committee Member Effective Immediately - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818219","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818219?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:06","pubTimestamp":1788343574,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17H:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664182148","title":"Starling Oncology - Brad Hively Will not Stand for Re-Election to Starling Oncology Board at 2027 Annual Meeting - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664182148","media":"THOMSON REUTERS","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664182148?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:06","pubTimestamp":1788343574,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nFWN44T17H:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4185","STLN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664818291","title":"Starling Oncology Director Brad Hively to Step Down as Vice Chairman, not Seek Re-Election in 2027","url":"https://stock-news.laohu8.com/highlight/detail?id=2664818291","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664818291?lang=en_us&edition=fundamental","pubTime":"2026-09-02 18:05","pubTimestamp":1788343526,"startTime":"0","endTime":"0","summary":"Starling Oncology director Brad Hively to step down as vice chairman, not seek re-election in 2027Starling Oncology director Brad Hively will not stand for re-election at the 2027 annual stockholders ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260902:nNDL98mpdb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["STLN","BK4185"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":6,"pageCount":1,"totalSize":23,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/STLN\",params:#limit:6,delay:false,,,undefined,":[]}}